Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
- Status
- COMPLETED
- Phase
- N/A
Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Status
- RECRUITING
- Phase
- PHASE2
Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP)
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
- Status
- TERMINATED
- Phase
- NA
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
- Status
- UNKNOWN
- Phase
- N/A
Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
CBT on Fatigue in Survivors of Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx
- Status
- COMPLETED
- Phase
- NA
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA